KIMBERLY MIZENER: Open Payments
NPI 1174860597 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 57 payments from 19 companies in 2025. Trend: 2023 $475 · 2024 $768 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 6 | $258 |
| Amgen Inc. | 8 | $199 |
| Dexcom, Inc. | 4 | $196 |
| Inspire Medical Systems, Inc. | 3 | $188 |
| Novo Nordisk Inc | 6 | $110 |
| GlaxoSmithKline, LLC. | 4 | $98 |
| Corcept Therapeutics | 3 | $68 |
| Exact Sciences Corporation | 4 | $64 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $50 |
Products named: Leqembi, INSPIRE, EVENITY, DEXCOM G7 GSS (161), TRELEGY ELLIPTA, Korlym, Veozah, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
